| |
PRODUCT NAME |
ORDER |
 |
NEOHESPERIDIN WITH HPLC |
 |
 |
NEOERIOCITRIN WITH HPLC |
 |
 |
2-Propanone,1-amino-3-(2-ethoxyphenoxy)-(9CI) |
 |
 |
1H-1,2,4-Triazole, 3-(1,1-dimethylethyl)-1-(1-oxopropyl)- (9CI) |
 |
 |
1H-1,2,4-Triazole, 1-acetyl-3-(1,1-dimethylethyl)- (9CI) |
 |
 |
2-Pyrrolidinone,5-hydroperoxy-1-methyl-(9CI) |
 |
 |
N-[(2,5-Dimethylphenyl)sulfonyl]glycine |
 |
 |
2,4(1H,3H)-Pyrimidinedione, 5-(2-propynyl)- (9CI) |
 |
 |
2-bromo-1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone |
 |
 |
5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenesulfonyl chloride |
 |
 |
5-Furan-2-yl-[1,3,4]oxadiazole-2-thiol |
 |
 |
N-Boc-N,-trityl-L-glutamine |
 |
 |
Boc-N-beta-Trityl-L-asparagine |
 |
 |
Fmoc-Gln(Trt)-Opfp |
 |
 |
Fmoc-Asn(Trt)-Opfp |
 |
 |
Z-Gln(Trt)-OH |
 |
 |
Fmoc-N-trityl-L-asparagine |
 |
 |
N,-Trityl-L-asparagine |
 |
 |
Z-Asn(Trt)-OH |
 |
 |
2,5-Diethylpyrazine |
 |
 |
Ethanimidamide, N-2-thiazolyl- |
 |
 |
Ethanimidamide, N-1,3,4-thiadiazol-2-yl- |
 |
 |
1,3-Cyclopentadiene,1-(1,1-dimethylethyl)-4-(1-methylethyl)-(9CI) |
 |
 |
7-BROMO-BICYCLO-(2,2,1)-HEPTANE |
 |
 |
Bicyclo[2.2.1]heptane, 2-bromo-, (1R,2S,4S)-rel- (9CI) |
 |
 |
1H-Tetrazole,5-[(4-ethoxyphenyl)methyl]-(9CI) |
 |
 |
1H-Tetrazole,5-[(3-ethoxyphenyl)methyl]-(9CI) |
 |
 |
1H-Tetrazole,5-[(2-ethoxyphenyl)methyl]-(9CI) |
 |
 |
5,5-Biisoxazole,3,3-dimethyl-(9CI) |
 |
 |
2-(3,5-DIMETHYLPYRAZOYL)-4,5-DIHYDROIMIDAZOLE HYDROBROMIDE |
 |
 |
1,3-Dioxolan-2-one, 4-methyl-5-(2-oxopropylidene)- |
 |
 |
1-Pentanone, 2,2-difluoro-3-hydroxy-1-phenyl- (9CI) |
 |
 |
Glycerol triglycidyl ether |
 |
 |
Pyridine, 2-(3-ethenyloxiranyl)-, trans- (9CI) |
 |
 |
Pyridine, 2-(3-ethenyloxiranyl)-, cis- (9CI) |
 |
 |
4(5H)-Thiazolone, 2-(dimethylamino)-5-methyl- |
 |
 |
Ethylenediaminetetraacetic acid tetrasodium salt |
 |
 |
1-Propen-2-ol, 1-(1-pyrrolidinyl)- (9CI) |
 |
 |
1-Pyrrolidineacetamide, N-(4-amino-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-5-pyrimidinyl)-2-oxo- (9CI) |
 |
 |
Cyclopropanecarboxamide, 2,3-dimethyl-1-nitro-, (1alpha,2alpha,3alpha)- (9CI) |
 |
 |
Carbamic acid, (2-oxo-3-oxetanyl)-, 1,1-dimethylethyl ester (9CI) |
 |
 |
PROPYLENE GLYCOL MONOSTEARATE; CONTAINS CA 40% MONOPALMITATE |
 |
 |
Benzoyl chloride, 4-(2-chlorocyclopropyl)- (9CI) |
 |
 |
S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate |
 |
 |
(S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine |
 |
 |
(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine |
 |
 |
Naphtho[2,3-c]furan-1,3-dione, 5,8-dimethyl- (9CI) |
 |
 |
Carbamic acid, (2,4-dimethyl-5-oxazolyl)-, ethyl ester (9CI) |
 |
 |
Propanamide, N-(2-ethyl-4-methyl-5-oxazolyl)- |
 |
 |
Acetamide, N-acetyl-N-(4-methyl-5-oxazolyl)- |
 |